![]() |
Volumn 22, Issue 4, 1999, Pages 326-
|
FDA comments on phase I clinical trials without vector biodistribution data [4]
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
VIRUS VECTOR;
DISTRIBUTION VOLUME;
FOOD AND DRUG ADMINISTRATION;
GENE EXPRESSION;
GENE INSERTION SEQUENCE;
GENE MUTATION;
GENE THERAPY;
GONAD;
LETTER;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
CLINICAL TRIALS, PHASE I;
GENE THERAPY;
GENETIC VECTORS;
GERM-LINE MUTATION;
HUMANS;
MUTAGENESIS, INSERTIONAL;
TISSUE DISTRIBUTION;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 0032769370
PISSN: 10614036
EISSN: None
Source Type: Journal
DOI: 10.1038/11895 Document Type: Letter |
Times cited : (3)
|
References (3)
|